JOHNSON & JOHNSON
JNJ Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-07-17
2025-07-18
REED JOHN
EVP, Innovative Medicine, R&D
S - Sale
Common Stock
-19,137
$163.55
-3.13M
1
$393.87B
2025-05-01
2025-05-05
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Restricted Share Units
-25,255
$0.00
1
$393.87B
2025-05-01
2025-05-05
REED JOHN
EVP, Innovative Medicine, R&D
F - Tax
Common Stock
-11,002
$156.00
-1.72M
1
$393.87B
2025-05-01
2025-05-05
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Common Stock
25,255
$0.00
1
$393.87B
2025-05-01
2025-05-05
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Restricted Share Units
-25,255
$0.00
1
$393.87B
2025-05-01
2025-05-05
REED JOHN
EVP, Innovative Medicine, R&D
F - Tax
Common Stock
-11,002
$156.00
-1.72M
1
$393.87B
2025-05-01
2025-05-05
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Common Stock
25,255
$0.00
1
$393.87B
2025-03-18
2025-03-19
DUATO JOAQUIN
CEO and Chairman of the Board
G - Gift
Common Stock
131K
$0.00
1
$393.87B
2025-03-18
2025-03-19
DUATO JOAQUIN
CEO and Chairman of the Board
G - Gift
Common Stock
-131K
$0.00
1
$393.87B
2025-02-25
2025-02-26
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
6,999
$102.00
714K
1
$393.87B
2025-02-25
2025-02-26
DECKER ROBERT
VP Corporate Controller
S - Sale
Common Stock
-6,999
$166.00
-1.16M
1
$393.87B
2025-02-25
2025-02-26
DECKER ROBERT
VP Corporate Controller
M - Exercise
Employee Stock Options (Right to Buy)
-6,999
$102.00
-714K
1
$393.87B
2025-02-15
2025-02-19
SCHMID TIMOTHY
EVP, WW Chair, MedTech
A - Grant
Employee Stock Options (Right to Buy)
49,878
$0.00
1
$393.87B
2025-02-15
2025-02-19
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Employee Stock Options (Right to Buy)
25,538
$0.00
1
$393.87B
2025-02-15
2025-02-19
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Restricted Share Units
1,576
$0.00
1
$393.87B
2025-02-15
2025-02-19
MULHOLLAND KRISTEN
EVP, Chief HR Officer
A - Grant
Employee Stock Options (Right to Buy)
27,951
$0.00
1
$393.87B
2025-02-15
2025-02-19
MULHOLLAND KRISTEN
EVP, Chief HR Officer
A - Grant
Restricted Share Units
1,725
$0.00
1
$393.87B
2025-02-15
2025-02-19
REED JOHN
EVP, Innovative Medicine, R&D
A - Grant
Employee Stock Options (Right to Buy)
89,781
$0.00
1
$393.87B
2025-02-15
2025-02-19
REED JOHN
EVP, Innovative Medicine, R&D
A - Grant
Restricted Share Units
5,539
$0.00
1
$393.87B
2025-02-15
2025-02-19
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
A - Grant
Employee Stock Options (Right to Buy)
89,781
$0.00
1
$393.87B
2025-02-15
2025-02-19
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
A - Grant
Restricted Share Units
5,539
$0.00
1
$393.87B
2025-02-15
2025-02-19
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Employee Stock Options (Right to Buy)
30,841
$0.00
1
$393.87B
2025-02-15
2025-02-19
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Restricted Share Units
1,903
$0.00
1
$393.87B
2025-02-15
2025-02-19
WOLK JOSEPH
Exec VP, CFO
A - Grant
Employee Stock Options (Right to Buy)
91,277
$0.00
1
$393.87B
2025-02-15
2025-02-19
SCHMID TIMOTHY
EVP, WW Chair, MedTech
A - Grant
Restricted Share Units
3,077
$0.00
1
$393.87B
2025-02-15
2025-02-19
SWANSON JAMES
EVP, CIO
A - Grant
Employee Stock Options (Right to Buy)
34,476
$0.00
1
$393.87B
2025-02-15
2025-02-19
DECKER ROBERT
VP Corporate Controller
A - Grant
Employee Stock Options (Right to Buy)
8,357
$0.00
1
$393.87B
2025-02-15
2025-02-19
DECKER ROBERT
VP Corporate Controller
A - Grant
Restricted Share Units
1,031
$0.00
1
$393.87B
2025-02-15
2025-02-19
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Employee Stock Options (Right to Buy)
219K
$0.00
1
$393.87B
2025-02-15
2025-02-19
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Restricted Share Units
13,513
$0.00
1
$393.87B
2025-02-15
2025-02-19
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Employee Stock Options (Right to Buy)
51,688
$0.00
1
$393.87B
2025-02-15
2025-02-19
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Restricted Share Units
3,189
$0.00
1
$393.87B
2025-02-18
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-651
$156.00
-102K
1
$393.87B
2025-02-18
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-200
$156.00
-31,200
1
$393.87B
2025-02-18
2025-02-18
REED JOHN
EVP, Innovative Medicine, R&D
F - Tax
Common Stock
-385
$156.00
-60,060
1
$393.87B
2025-02-18
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
F - Tax
Common Stock
-120
$156.00
-18,720
1
$393.87B
2025-02-18
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
F - Tax
Common Stock
-307
$156.00
-47,892
1
$393.87B
2025-02-18
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-1,602
$156.00
-250K
1
$393.87B
2025-02-18
2025-02-18
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-94
$156.00
-14,664
1
$393.87B
2025-02-18
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-158
$156.00
-24,648
1
$393.87B
2025-02-18
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
S - Sale
Common Stock
-403
$156.00
-62,868
1
$393.87B
2025-02-15
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
339
$0.00
1
$393.87B
2025-02-15
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Restricted Share Units
-339
$0.00
1
$393.87B
2025-02-15
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
492
$0.00
1
$393.87B
2025-02-15
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
3,682
$0.00
1
$393.87B
2025-02-15
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Restricted Share Units
-1,971
$0.00
1
$393.87B
2025-02-15
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
1,594
$0.00
1
$393.87B
2025-02-15
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Restricted Share Units
-607
$0.00
1
$393.87B
2025-02-15
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
607
$0.00
1
$393.87B
2025-02-15
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-492
$0.00
1
$393.87B
2025-02-15
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Restricted Share Units
-1,594
$0.00
1
$393.87B
2025-02-15
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Restricted Share Units
-961
$0.00
1
$393.87B
2025-02-15
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
961
$0.00
1
$393.87B
2025-02-15
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Restricted Share Units
-419
$0.00
1
$393.87B
2025-02-15
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Common Stock
419
$0.00
1
$393.87B
2025-02-15
2025-02-18
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Restricted Share Units
-1,350
$0.00
1
$393.87B
2025-02-15
2025-02-18
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Common Stock
1,350
$0.00
1
$393.87B
2025-02-15
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Restricted Share Units
-1,029
$0.00
1
$393.87B
2025-02-15
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
1,029
$0.00
1
$393.87B
2025-02-15
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Restricted Share Units
-3,682
$0.00
1
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Performance Share Units
-15,465
$0.00
1
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Restricted Share Units
-4,053
$0.00
1
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
19,518
$0.00
2
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Performance Share Units
-5,837
$0.00
1
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Restricted Share Units
-1,530
$0.00
1
$393.87B
2025-02-14
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Performance Share Units
-15,316
$0.00
1
$393.87B
2025-02-14
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Restricted Share Units
-4,014
$0.00
1
$393.87B
2025-02-14
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Restricted Share Units
-4,014
$0.00
1
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
7,367
$0.00
2
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-1,722
$157.00
-270K
3
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-730
$157.00
-115K
3
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-12,094
$157.00
-1.90M
3
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
F - Tax
Common Stock
-946
$156.00
-148K
3
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
F - Tax
Common Stock
-888
$156.00
-139K
3
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
F - Tax
Common Stock
-1,847
$157.00
-290K
3
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-9,669
$157.00
-1.52M
3
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-3,096
$157.00
-486K
3
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-9,669
$157.00
-1.52M
3
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-3,096
$157.00
-486K
3
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
4,740
$0.00
2
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Performance Share Units
-1,351
$0.00
1
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Restricted Share Units
-850
$0.00
1
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
2,201
$0.00
2
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Performance Share Units
-19,282
$0.00
1
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Restricted Share Units
-5,053
$0.00
1
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
24,335
$0.00
2
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Performance Share Units
-1,352
$0.00
1
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Restricted Share Units
-851
$0.00
1
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
2,203
$0.00
2
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Performance Share Units
-1,601
$0.00
1
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Restricted Share Units
-1,007
$0.00
1
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Common Stock
2,608
$0.00
2
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Performance Share Units
-2,806
$0.00
1
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
4,571
$0.00
2
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Performance Share Units
-15,465
$0.00
1
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Restricted Share Units
-4,053
$0.00
1
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
19,518
$0.00
2
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Performance Share Units
-5,837
$0.00
1
$393.87B
2025-02-14
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Performance Share Units
-15,316
$0.00
1
$393.87B
2025-02-14
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Restricted Share Units
-4,014
$0.00
1
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-12,094
$157.00
-1.90M
3
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
F - Tax
Common Stock
-888
$156.00
-139K
3
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
F - Tax
Common Stock
-1,847
$157.00
-290K
3
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-9,669
$157.00
-1.52M
3
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-3,096
$157.00
-486K
3
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
4,740
$0.00
2
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Performance Share Units
-1,351
$0.00
1
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Restricted Share Units
-850
$0.00
1
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
2,201
$0.00
2
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Performance Share Units
-19,282
$0.00
1
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Restricted Share Units
-5,053
$0.00
1
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-1,830
$0.00
1
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
24,335
$0.00
2
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Performance Share Units
-1,352
$0.00
1
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Restricted Share Units
-851
$0.00
1
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
2,203
$0.00
2
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Performance Share Units
-1,601
$0.00
1
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Restricted Share Units
-1,007
$0.00
1
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Restricted Share Units
-851
$0.00
1
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
2,203
$0.00
2
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Performance Share Units
-1,601
$0.00
1
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Restricted Share Units
-1,007
$0.00
1
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Common Stock
2,608
$0.00
2
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Performance Share Units
-2,806
$0.00
1
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Restricted Share Units
-1,765
$0.00
1
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
4,571
$0.00
2
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Performance Share Units
-15,465
$0.00
1
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Restricted Share Units
-4,053
$0.00
1
$393.87B
2025-02-14
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
19,518
$0.00
2
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Performance Share Units
-5,837
$0.00
1
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Restricted Share Units
-1,530
$0.00
1
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
7,367
$0.00
2
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Common Stock
2,608
$0.00
2
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Performance Share Units
-2,806
$0.00
1
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Restricted Share Units
-1,765
$0.00
1
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
4,571
$0.00
2
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Performance Share Units
-2,910
$0.00
1
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-1,830
$0.00
1
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Restricted Share Units
-1,765
$0.00
1
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Restricted Share Units
-1,530
$0.00
1
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
F - Tax
Common Stock
-946
$156.00
-148K
3
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Performance Share Units
-2,910
$0.00
1
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Performance Share Units
-2,910
$0.00
1
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-1,830
$0.00
1
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
4,740
$0.00
2
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Performance Share Units
-1,351
$0.00
1
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Restricted Share Units
-850
$0.00
1
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
2,201
$0.00
2
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Performance Share Units
-19,282
$0.00
1
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Restricted Share Units
-5,053
$0.00
1
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
24,335
$0.00
2
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Performance Share Units
-1,352
$0.00
1
$393.87B
2025-02-14
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
7,367
$0.00
2
$393.87B
2025-02-14
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Performance Share Units
-15,316
$0.00
1
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-1,722
$157.00
-270K
3
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-730
$157.00
-115K
3
$393.87B
2025-02-14
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-12,094
$157.00
-1.90M
3
$393.87B
2025-02-14
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
F - Tax
Common Stock
-946
$156.00
-148K
3
$393.87B
2025-02-14
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
F - Tax
Common Stock
-888
$156.00
-139K
3
$393.87B
2025-02-14
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-1,722
$157.00
-270K
3
$393.87B
2025-02-14
2025-02-18
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-730
$157.00
-115K
3
$393.87B
2025-02-14
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
F - Tax
Common Stock
-1,847
$157.00
-290K
3
$393.87B
2025-02-13
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Restricted Share Units
-1,302
$0.00
1
$393.87B
2025-02-13
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-408
$0.00
1
$393.87B
2025-02-13
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
499
$0.00
1
$393.87B
2025-02-13
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Restricted Share Units
-411
$0.00
1
$393.87B
2025-02-13
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
651
$0.00
1
$393.87B
2025-02-13
2025-02-18
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Restricted Share Units
-651
$0.00
1
$393.87B
2025-02-13
2025-02-18
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Restricted Share Units
-1,779
$0.00
1
$393.87B
2025-02-13
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
3,470
$0.00
1
$393.87B
2025-02-13
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
651
$0.00
1
$393.87B
2025-02-13
2025-02-18
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Restricted Share Units
-651
$0.00
1
$393.87B
2025-02-13
2025-02-18
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
1,302
$0.00
1
$393.87B
2025-02-13
2025-02-18
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Restricted Share Units
-499
$0.00
1
$393.87B
2025-02-13
2025-02-18
MULHOLLAND KRISTEN
EVP, Chief HR Officer
M - Exercise
Common Stock
411
$0.00
1
$393.87B
2025-02-13
2025-02-18
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
408
$0.00
1
$393.87B
2025-02-13
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Restricted Share Units
-312
$0.00
1
$393.87B
2025-02-13
2025-02-18
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Restricted Share Units
-3,470
$0.00
1
$393.87B
2025-02-13
2025-02-18
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
312
$0.00
1
$393.87B
2025-02-10
2025-02-12
DECKER ROBERT
VP Corporate Controller
A - Grant
Performance Share Units
1,351
$0.00
1
$393.87B
2025-02-10
2025-02-12
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Performance Share Units
1,352
$0.00
1
$393.87B
2025-02-10
2025-02-12
MULHOLLAND KRISTEN
EVP, Chief HR Officer
A - Grant
Performance Share Units
1,601
$0.00
1
$393.87B
2025-02-10
2025-02-12
SCHMID TIMOTHY
EVP, WW Chair, MedTech
A - Grant
Performance Share Units
2,806
$0.00
1
$393.87B
2025-02-10
2025-02-12
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
A - Grant
Performance Share Units
15,465
$0.00
1
$393.87B
2025-02-10
2025-02-12
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Performance Share Units
5,837
$0.00
1
$393.87B
2025-02-10
2025-02-12
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Performance Share Units
2,910
$0.00
1
$393.87B
2025-02-10
2025-02-12
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Performance Share Units
19,282
$0.00
1
$393.87B
2025-02-07
2025-02-11
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-26,076
$153.00
-3.99M
1
$393.87B
2025-02-07
2025-02-11
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Employee Stock Options (Right to Buy)
-126K
$100.00
-13M
1
$393.87B
2025-02-07
2025-02-11
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
126K
$100.00
13M
1
$393.87B
2025-02-07
2025-02-11
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Employee Stock Options (Right to Buy)
-58,504
$100.00
-5.85M
1
$393.87B
2025-02-07
2025-02-11
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
58,504
$100.00
5.85M
1
$393.87B
2025-02-07
2025-02-11
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Employee Stock Options (Right to Buy)
-32,762
$100.00
-3.28M
1
$393.87B
2025-02-07
2025-02-11
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
32,762
$100.00
3.28M
1
$393.87B
2025-02-07
2025-02-11
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Employee Stock Options (Right to Buy)
-13,015
$100.00
-1.30M
1
$393.87B
2025-02-07
2025-02-11
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-47,436
$153.00
-7.26M
1
$393.87B
2025-02-07
2025-02-11
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-101K
$153.00
-15M
1
$393.87B
2025-02-07
2025-02-11
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-47,436
$153.00
-7.26M
1
$393.87B
2025-02-07
2025-02-11
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-26,076
$153.00
-3.99M
1
$393.87B
2025-02-07
2025-02-11
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Employee Stock Options (Right to Buy)
-126K
$100.00
-13M
1
$393.87B
2025-02-07
2025-02-11
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
126K
$100.00
13M
1
$393.87B
2025-02-07
2025-02-11
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Employee Stock Options (Right to Buy)
-58,504
$100.00
-5.85M
1
$393.87B
2025-02-07
2025-02-11
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
58,504
$100.00
5.85M
1
$393.87B
2025-02-07
2025-02-11
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Employee Stock Options (Right to Buy)
-32,762
$100.00
-3.28M
1
$393.87B
2025-02-07
2025-02-11
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
32,762
$100.00
3.28M
1
$393.87B
2025-02-07
2025-02-11
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Employee Stock Options (Right to Buy)
-13,015
$100.00
-1.30M
1
$393.87B
2025-02-07
2025-02-11
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-101K
$153.00
-15M
1
$393.87B
2024-12-04
2024-12-04
HAIT WILLIAM
EVP, Chief EI and Med Officer
S - Sale
-25,742
$150.00
-3.86M
1
$393.87B
2024-05-01
2024-10-31
REED JOHN
EVP, Innovative Medicine, R&D
F - Tax
Common Stock
-10,984
$145.00
-1.59M
1
$393.87B
2024-05-01
2024-10-31
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Restricted Share Units
-25,255
$0.00
1
$393.87B
2024-05-01
2024-10-31
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Common Stock
25,255
$0.00
1
$393.87B
2024-08-30
2024-09-03
DECKER ROBERT
VP Corporate Controller
M - Exercise
Employee Stock Options (Right to Buy)
-5,635
$0.00
1
$393.87B
2024-08-30
2024-09-03
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
5,635
$100.00
564K
1
$393.87B
2024-08-30
2024-09-03
DECKER ROBERT
VP Corporate Controller
S - Sale
Common Stock
-5,635
$165.00
-930K
1
$393.87B
2024-07-08
2024-07-09
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-5,018
$147.00
-738K
1
$393.87B
2024-07-08
2024-07-09
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-9,809
$0.00
1
$393.87B
2024-07-08
2024-07-09
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
9,809
$0.00
1
$393.87B
2024-05-01
2024-05-03
REED JOHN
EVP, Innovative Medicine, R&D
F - Tax
Common Stock
-10,984
$145.00
-1.59M
1
$393.87B
2024-05-01
2024-05-03
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Restricted Share Units
-22,255
$0.00
1
$393.87B
2024-05-01
2024-05-03
REED JOHN
EVP, Innovative Medicine, R&D
M - Exercise
Common Stock
22,255
$0.00
1
$393.87B
2024-03-13
2024-03-13
BROADHURST VANESSA
EVP, Global Corp Affairs
S - Sale
Common Stock
-8,891
$162.00
-1.44M
1
$393.87B
2024-02-15
2024-02-20
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Restricted Share Units
1,475
$0.00
1
$393.87B
2024-02-15
2024-02-20
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Employee Stock Options (Right to Buy)
23,745
$0.00
1
$393.87B
2024-02-15
2024-02-20
DECKER ROBERT
VP Corporate Controller
A - Grant
Employee Stock Options (Right to Buy)
8,175
$0.00
1
$393.87B
2024-02-15
2024-02-20
DECKER ROBERT
VP Corporate Controller
A - Grant
Restricted Share Units
1,016
$0.00
1
$393.87B
2024-02-15
2024-02-20
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Employee Stock Options (Right to Buy)
178K
$0.00
1
$393.87B
2024-02-15
2024-02-20
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Restricted Share Units
11,046
$0.00
1
$393.87B
2024-02-15
2024-02-20
FASOLO PETER
Exec VP, Chief HR Officer
A - Grant
Employee Stock Options (Right to Buy)
40,551
$0.00
1
$393.87B
2024-02-15
2024-02-20
FASOLO PETER
Exec VP, Chief HR Officer
A - Grant
Restricted Share Units
2,519
$0.00
1
$393.87B
2024-02-15
2024-02-20
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Employee Stock Options (Right to Buy)
46,406
$0.00
1
$393.87B
2024-02-15
2024-02-20
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Restricted Share Units
2,883
$0.00
1
$393.87B
2024-02-15
2024-02-20
HAIT WILLIAM
EVP, Chief EI and Med Officer
A - Grant
Employee Stock Options (Right to Buy)
34,696
$0.00
1
$393.87B
2024-02-15
2024-02-20
HAIT WILLIAM
EVP, Chief EI and Med Officer
A - Grant
Restricted Share Units
2,155
$0.00
1
$393.87B
2024-02-15
2024-02-20
REED JOHN
EVP, Innovative Medicine, R&D
A - Grant
Employee Stock Options (Right to Buy)
65,163
$0.00
1
$393.87B
2024-02-15
2024-02-20
REED JOHN
EVP, Innovative Medicine, R&D
A - Grant
Restricted Share Units
4,048
$0.00
1
$393.87B
2024-02-15
2024-02-20
SCHMID TIMOTHY
EVP, WW Chair, MedTech
A - Grant
Employee Stock Options (Right to Buy)
49,658
$0.00
1
$393.87B
2024-02-15
2024-02-20
SCHMID TIMOTHY
EVP, WW Chair, MedTech
A - Grant
Restricted Share Units
3,085
$0.00
1
$393.87B
2024-02-15
2024-02-20
SWANSON JAMES
EVP, CIO
A - Grant
Employee Stock Options (Right to Buy)
23,745
$0.00
1
$393.87B
2024-02-15
2024-02-20
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
A - Grant
Employee Stock Options (Right to Buy)
76,981
$0.00
1
$393.87B
2024-02-15
2024-02-20
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
A - Grant
Restricted Share Units
4,782
$0.00
1
$393.87B
2024-02-15
2024-02-20
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Employee Stock Options (Right to Buy)
29,275
$0.00
1
$393.87B
2024-02-15
2024-02-20
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Restricted Share Units
1,819
$0.00
1
$393.87B
2024-02-15
2024-02-20
WOLK JOSEPH
Exec VP, CFO
A - Grant
Employee Stock Options (Right to Buy)
95,197
$0.00
1
$393.87B
2024-02-13
2024-02-15
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
499
$0.00
1
$393.87B
2024-02-13
2024-02-15
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Restricted Share Units
-1,302
$0.00
1
$393.87B
2024-02-13
2024-02-15
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
1,302
$0.00
1
$393.87B
2024-02-13
2024-02-15
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Restricted Share Units
-651
$0.00
1
$393.87B
2024-02-13
2024-02-15
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-209
$158.00
-33,022
1
$393.87B
2024-02-13
2024-02-15
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-86
$158.00
-13,588
1
$393.87B
2024-02-13
2024-02-15
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-1,507
$158.00
-238K
1
$393.87B
2024-02-13
2024-02-15
FASOLO PETER
Exec VP, Chief HR Officer
F - Tax
Common Stock
-474
$158.00
-74,892
1
$393.87B
2024-02-13
2024-02-15
FORMINARD ELIZABETH
Executive VP, General Counsel
F - Tax
Common Stock
-236
$158.00
-37,288
1
$393.87B
2024-02-13
2024-02-15
SCHMID TIMOTHY
EVP, WW Chair, MedTech
F - Tax
Common Stock
-250
$158.00
-39,500
1
$393.87B
2024-02-13
2024-02-15
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-666
$158.00
-105K
1
$393.87B
2024-02-13
2024-02-15
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-333
$158.00
-52,614
1
$393.87B
2024-02-13
2024-02-15
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-408
$0.00
1
$393.87B
2024-02-13
2024-02-15
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
408
$0.00
1
$393.87B
2024-02-13
2024-02-15
DECKER ROBERT
VP Corporate Controller
M - Exercise
Restricted Share Units
-313
$0.00
1
$393.87B
2024-02-13
2024-02-15
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
313
$0.00
1
$393.87B
2024-02-13
2024-02-15
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Restricted Share Units
-3,470
$0.00
1
$393.87B
2024-02-13
2024-02-15
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
3,470
$0.00
1
$393.87B
2024-02-13
2024-02-15
FASOLO PETER
Exec VP, Chief HR Officer
M - Exercise
Restricted Share Units
-925
$0.00
1
$393.87B
2024-02-13
2024-02-15
FASOLO PETER
Exec VP, Chief HR Officer
M - Exercise
Common Stock
925
$0.00
1
$393.87B
2024-02-13
2024-02-15
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Restricted Share Units
-651
$0.00
1
$393.87B
2024-02-13
2024-02-15
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
651
$0.00
1
$393.87B
2024-02-13
2024-02-15
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Restricted Share Units
-499
$0.00
1
$393.87B
2024-02-13
2024-02-15
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
651
$0.00
1
$393.87B
2024-02-13
2024-02-15
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Restricted Share Units
-1,780
$0.00
1
$393.87B
2024-02-12
2024-02-14
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
F - Tax
Common Stock
-13,403
$157.00
-2.10M
1
$393.87B
2024-02-12
2024-02-14
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Common Stock
790
$0.00
1
$393.87B
2024-02-12
2024-02-14
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-2,136
$157.00
-335K
1
$393.87B
2024-02-12
2024-02-14
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-523
$157.00
-82,111
1
$393.87B
2024-02-12
2024-02-14
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-15,900
$157.00
-2.50M
1
$393.87B
2024-02-12
2024-02-14
FASOLO PETER
Exec VP, Chief HR Officer
F - Tax
Common Stock
-7,019
$157.00
-1.10M
1
$393.87B
2024-02-12
2024-02-14
FORMINARD ELIZABETH
Executive VP, General Counsel
F - Tax
Common Stock
-1,034
$157.00
-162K
1
$393.87B
2024-02-12
2024-02-14
SCHMID TIMOTHY
EVP, WW Chair, MedTech
F - Tax
Common Stock
-2,887
$157.00
-453K
1
$393.87B
2024-02-12
2024-02-14
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
13,813
$0.00
2
$393.87B
2024-02-12
2024-02-14
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-7,066
$157.00
-1.11M
1
$393.87B
2024-02-12
2024-02-14
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Performance Share Units
-4,701
$0.00
1
$393.87B
2024-02-12
2024-02-14
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
4,701
$0.00
1
$393.87B
2024-02-12
2024-02-14
DECKER ROBERT
VP Corporate Controller
M - Exercise
Performance Share Units
-1,637
$0.00
1
$393.87B
2024-02-12
2024-02-14
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
1,912
$0.00
2
$393.87B
2024-02-12
2024-02-14
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Performance Share Units
-31,351
$0.00
1
$393.87B
2024-02-12
2024-02-14
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
36,618
$0.00
2
$393.87B
2024-02-12
2024-02-14
FASOLO PETER
Exec VP, Chief HR Officer
M - Exercise
Performance Share Units
-12,808
$0.00
1
$393.87B
2024-02-12
2024-02-14
FASOLO PETER
Exec VP, Chief HR Officer
M - Exercise
Common Stock
14,960
$0.00
2
$393.87B
2024-02-12
2024-02-14
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Performance Share Units
-2,448
$0.00
1
$393.87B
2024-02-12
2024-02-14
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
2,859
$0.00
2
$393.87B
2024-02-12
2024-02-14
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Common Stock
26,202
$0.00
2
$393.87B
2024-02-12
2024-02-14
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Performance Share Units
-4,911
$0.00
1
$393.87B
2024-02-12
2024-02-14
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
5,736
$0.00
2
$393.87B
2024-02-12
2024-02-14
TAUBERT JENNIFER
EVP, WWC. Innovative Medicine
M - Exercise
Performance Share Units
-22,433
$0.00
1
$393.87B
2024-02-12
2024-02-14
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Performance Share Units
-22,119
$0.00
1
$393.87B
2024-02-12
2024-02-14
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Performance Share Units
-11,826
$0.00
1
$393.87B
2024-02-09
2024-02-13
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-98,662
$157.00
-15M
1
$393.87B
2024-02-09
2024-02-13
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-27,333
$157.00
-4.29M
1
$393.87B
2024-02-09
2024-02-13
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Employee Stock Options (Right to Buy)
-131K
$90.00
-12M
1
$393.87B
2024-02-09
2024-02-13
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
131K
$90.00
12M
1
$393.87B
2024-02-09
2024-02-13
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Employee Stock Options (Right to Buy)
-35,638
$90.00
-3.21M
1
$393.87B
2024-02-09
2024-02-13
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
35,638
$90.00
3.21M
1
$393.87B
2024-02-09
2024-02-12
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
M - Exercise
Employee Stock Options (Right to Buy)
-59,397
$0.00
1
$393.87B
2024-02-09
2024-02-12
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
S - Sale
Common Stock
-59,397
$156.00
-9.27M
1
$393.87B
2024-02-09
2024-02-12
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
M - Exercise
Common Stock
59,397
$90.00
5.35M
1
$393.87B
2024-02-08
2024-02-12
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Common Stock
1,964
$0.00
1
$393.87B
2024-02-08
2024-02-12
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-703
$156.00
-110K
1
$393.87B
2024-02-08
2024-02-12
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-215
$156.00
-33,540
1
$393.87B
2024-02-08
2024-02-12
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-2,269
$156.00
-354K
1
$393.87B
2024-02-08
2024-02-12
FASOLO PETER
Exec VP, Chief HR Officer
F - Tax
Common Stock
-781
$156.00
-122K
1
$393.87B
2024-02-08
2024-02-12
FORMINARD ELIZABETH
Executive VP, General Counsel
F - Tax
Common Stock
-363
$156.00
-56,628
1
$393.87B
2024-02-08
2024-02-12
SCHMID TIMOTHY
EVP, WW Chair, MedTech
F - Tax
Common Stock
-1,001
$156.00
-156K
1
$393.87B
2024-02-08
2024-02-12
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
F - Tax
Common Stock
-1,913
$156.00
-298K
1
$393.87B
2024-02-08
2024-02-12
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-1,009
$156.00
-157K
1
$393.87B
2024-02-08
2024-02-12
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Restricted Share Units
-1,880
$0.00
1
$393.87B
2024-02-08
2024-02-12
BROADHURST VANESSA
EVP, Global Corp Affairs
M - Exercise
Common Stock
1,880
$0.00
1
$393.87B
2024-02-08
2024-02-12
DECKER ROBERT
VP Corporate Controller
M - Exercise
Restricted Share Units
-655
$0.00
1
$393.87B
2024-02-08
2024-02-12
DECKER ROBERT
VP Corporate Controller
M - Exercise
Common Stock
655
$0.00
1
$393.87B
2024-02-08
2024-02-12
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Restricted Share Units
-5,225
$0.00
1
$393.87B
2024-02-08
2024-02-12
DUATO JOAQUIN
CEO and Chairman of the Board
M - Exercise
Common Stock
5,225
$0.00
1
$393.87B
2024-02-08
2024-02-12
FASOLO PETER
Exec VP, Chief HR Officer
M - Exercise
Restricted Share Units
-2,135
$0.00
1
$393.87B
2024-02-08
2024-02-12
FASOLO PETER
Exec VP, Chief HR Officer
M - Exercise
Common Stock
2,135
$0.00
1
$393.87B
2024-02-08
2024-02-12
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Restricted Share Units
-979
$0.00
1
$393.87B
2024-02-08
2024-02-12
FORMINARD ELIZABETH
Executive VP, General Counsel
M - Exercise
Common Stock
979
$0.00
1
$393.87B
2024-02-08
2024-02-12
SCHMID TIMOTHY
EVP, WW Chair, MedTech
M - Exercise
Restricted Share Units
-1,964
$0.00
1
$393.87B
2024-02-08
2024-02-12
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
M - Exercise
Restricted Share Units
-3,739
$0.00
1
$393.87B
2024-02-08
2024-02-12
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
M - Exercise
Common Stock
3,739
$0.00
1
$393.87B
2024-02-08
2024-02-12
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Restricted Share Units
-1,971
$0.00
1
$393.87B
2024-02-08
2024-02-12
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
M - Exercise
Common Stock
1,971
$0.00
1
$393.87B
2024-02-08
2024-02-12
WOLK JOSEPH
Exec VP, CFO
M - Exercise
Restricted Share Units
-3,686
$0.00
1
$393.87B
2023-08-23
2023-08-25
DUATO JOAQUIN
CEO and Chairman of the Board
D - Sale to Issuer
Common Stock
-11,035
$0.00
1
$393.87B
2023-08-23
2023-08-25
FASOLO PETER
Exec VP, Chief HR Officer
D - Sale to Issuer
Common Stock
-232
$0.00
1
$393.87B
2023-08-23
2023-08-25
MCEVOY ASHLEY
EVP, WW Chair, MedTech
D - Sale to Issuer
Common Stock
-2,787
$0.00
1
$393.87B
2023-07-26
2023-07-27
HAIT WILLIAM
M - Exercise
Employee Stock Options (Right to Buy)
-14,698
$0.00
1
$393.87B
2023-07-25
2023-07-27
FASOLO PETER
Exec VP, Chief HR Officer
S - Sale
Common Stock
-20,000
$170.00
-3.40M
1
$393.87B
2023-06-12
2023-06-14
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
S - Sale
Common Stock
-12,465
$160.00
-1.99M
1
$393.87B
2023-05-01
2023-05-02
REED JOHN
EVP, Pharmaceuticals R&D
A - Grant
Restricted Share Units
75,765
$0.00
1
$393.87B
2023-02-13
2023-02-15
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Restricted Share Units
1,953
$0.00
1
$393.87B
2023-02-13
2023-02-15
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
F - Tax
Common Stock
-10,569
$162.00
-1.71M
1
$393.87B
2023-02-13
2023-02-15
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
F - Tax
Common Stock
-4,891
$162.00
-792K
1
$393.87B
2023-02-13
2023-02-15
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Employee Stock Options (Right to Buy)
20,263
$0.00
1
$393.87B
2023-02-13
2023-02-15
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Restricted Share Units
1,224
$0.00
1
$393.87B
2023-02-13
2023-02-15
BROADHURST VANESSA
EVP, Global Corp Affairs
A - Grant
Common Stock
3,981
$0.00
1
$393.87B
2023-02-13
2023-02-15
DECKER ROBERT
VP Corporate Controller
A - Grant
Employee Stock Options (Right to Buy)
7,756
$0.00
1
$393.87B
2023-02-13
2023-02-15
DECKER ROBERT
VP Corporate Controller
A - Grant
Restricted Share Units
937
$0.00
1
$393.87B
2023-02-13
2023-02-15
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Employee Stock Options (Right to Buy)
172K
$0.00
1
$393.87B
2023-02-13
2023-02-15
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Restricted Share Units
10,409
$0.00
1
$393.87B
2023-02-13
2023-02-15
DUATO JOAQUIN
CEO and Chairman of the Board
A - Grant
Common Stock
31,319
$0.00
1
$393.87B
2023-02-13
2023-02-15
FASOLO PETER
Exec VP, Chief HR Officer
A - Grant
Employee Stock Options (Right to Buy)
45,890
$0.00
1
$393.87B
2023-02-13
2023-02-15
FASOLO PETER
Exec VP, Chief HR Officer
A - Grant
Restricted Share Units
2,773
$0.00
1
$393.87B
2023-02-13
2023-02-15
FASOLO PETER
Exec VP, Chief HR Officer
A - Grant
Common Stock
12,468
$0.00
1
$393.87B
2023-02-13
2023-02-15
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Employee Stock Options (Right to Buy)
32,317
$0.00
1
$393.87B
2023-02-13
2023-02-15
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Restricted Share Units
1,953
$0.00
1
$393.87B
2023-02-13
2023-02-15
FORMINARD ELIZABETH
Executive VP, General Counsel
A - Grant
Common Stock
2,555
$0.00
1
$393.87B
2023-02-13
2023-02-15
HAIT WILLIAM
A - Grant
Employee Stock Options (Right to Buy)
41,366
$0.00
1
$393.87B
2023-02-13
2023-02-15
MCEVOY ASHLEY
EVP, WW Chair, MedTech
A - Grant
Employee Stock Options (Right to Buy)
61,295
$0.00
1
$393.87B
2023-02-13
2023-02-15
MCEVOY ASHLEY
EVP, WW Chair, MedTech
A - Grant
Restricted Share Units
3,704
$0.00
1
$393.87B
2023-02-13
2023-02-15
MONGON THIBAUT
Exec VP, WW Chair, Cons Health
A - Grant
Employee Stock Options (Right to Buy)
56,555
$0.00
1
$393.87B
2023-02-13
2023-02-15
MONGON THIBAUT
Exec VP, WW Chair, Cons Health
A - Grant
Restricted Share Units
3,417
$0.00
1
$393.87B
2023-02-13
2023-02-15
MONGON THIBAUT
Exec VP, WW Chair, Cons Health
A - Grant
Common Stock
13,710
$0.00
1
$393.87B
2023-02-13
2023-02-15
SWANSON JAMES
A - Grant
Employee Stock Options (Right to Buy)
22,191
$0.00
1
$393.87B
2023-02-13
2023-02-15
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
A - Grant
Employee Stock Options (Right to Buy)
64,634
$0.00
1
$393.87B
2023-02-13
2023-02-15
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
A - Grant
Restricted Share Units
3,906
$0.00
1
$393.87B
2023-02-13
2023-02-15
TAUBERT JENNIFER
EVP, WW Chair, Pharmaceuticals
A - Grant
Common Stock
21,422
$0.00
1
$393.87B
2023-02-13
2023-02-15
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Employee Stock Options (Right to Buy)
32,317
$0.00
1
$393.87B
2023-02-13
2023-02-15
WENGEL KATHRYN
EVP, Chief TO and Risk Officer
A - Grant
Common Stock
10,839
$0.00
1
$393.87B
2023-02-13
2023-02-15
WOLK JOSEPH
Exec VP, CFO
A - Grant
Employee Stock Options (Right to Buy)
88,334
$0.00
1
$393.87B
2023-02-13
2023-02-15
BROADHURST VANESSA
EVP, Global Corp Affairs
F - Tax
Common Stock
-1,440
$162.00
-233K
1
$393.87B
2023-02-13
2023-02-15
DECKER ROBERT
VP Corporate Controller
F - Tax
Common Stock
-397
$162.00
-64,314
1
$393.87B
2023-02-13
2023-02-15
DUATO JOAQUIN
CEO and Chairman of the Board
F - Tax
Common Stock
-13,599
$162.00
-2.20M
1
$393.87B